Share：
Share this content in WeChat
X
[Chinese][PDF]130593
• Clinical Article •
The performance of pretreatment MRI based nomogram in neoadjuvant chemotherapy response prediction in nasopharyngeal carcinoma: A primary study
ZHENG Dechun  XU Shugui  LAI Guojing  CHEN Jiayou  REN Wang  CHEN Yunbin 

Cite this article as: Zheng DC, Xu SG, Lai GJ, et al. The performance of pretreatment MRI based nomogram in neoadjuvant chemotherapy response prediction in nasopharyngeal carcinoma: A primary study[J]. Chin J Magn Reson Imaging, 2021, 12(4): 23-29. DOI:10.12015/issn.1674-8034.2021.04.005.


[Abstract] Objective To investigate a pretreatment MRI based nomogram in predicting neoadjuvant chemotherapy (NAC) response in nasopharyngeal carcinoma (NPC). Materials andMethods Totally 191 patients with NPC were retrospectively enrolled. The volume of interest of every primary nasopharyngeal tumor was contoured on T2WI_FS and T1WI_CE by two experienced doctors and imaging features were extracted. Age, sex, pathologic type, TNM staging and morphologic size of lesions were collected as clinical factors. maximum relevance minimum redundancy (mRMR) and least absolute shrinkage and selection operator (LASSO) were sequentially implied to reduce redundancy of imaging features from T2WI_FS and T1WI_CE before radscore calculation. Afterwards, an MRI based nomograms consolidating imaging features and clinical factors were developed based on multivariate logistic regression respectively. ROC curves analysis was performed to assess and compare the performance of three different models; then calibration curve from Hosmer-Lemeshow test and decision curve were acquired.Results A total of 101 NPC patients was categorized as responders after two NAC cycles treatment. Chi-square test demonstrated that T stage was statistical significance between responder and non-responder group (P=0.046). Both the overall performance of nomogram and radiomics model to distinguish responder from non-responders group were moderate. The AUC of nomogram and radiomics model stood at 0.72 [95% CI: 0.63—0.81] for training cohort. And the corresponding AUC in validate cohort were 0.72 (95% CI: 0.59—0.85) and 0.77 (95% CI: 0.74—0.89) for nomogram and radiomics respectively. The accuracy of nomogram for NAC response assessment in NPC was higher than clinics model (0.687 vs. 0.604). It was also suggested mild improvement in nomogram compared to radiomics (0.687 vs. 0.679).Conclusions Pretreatment MRI based nomogram could predict NAC response in NPC, its accuracy was better than clinics model.
[Keywords] nasopharyngeal neoplasms；radiomics；magnetic resonance imaging；neoadjuvant chemotherapy；therapy response

ZHENG Dechun1*   XU Shugui1   LAI Guojing2   CHEN Jiayou1   REN Wang1   CHEN Yunbin1  

1 Department of Radiology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China

2 Department of Radiation Therapy Center, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China

Zheng DC, E-mail: Dechun.zheng@139.com

Conflicts of interest   None.

This work was part of Natural Science Foundation of Fujian Province (No. 2017J01180); Science and Technology Program of Fujian Province (No. 2018Y2003) and Scholarship for Studying Abroad in Fujian Province.
Received  2020-07-22
Accepted  2021-01-12
DOI: 10.12015/issn.1674-8034.2021.04.005
Cite this article as: Zheng DC, Xu SG, Lai GJ, et al. The performance of pretreatment MRI based nomogram in neoadjuvant chemotherapy response prediction in nasopharyngeal carcinoma: A primary study[J]. Chin J Magn Reson Imaging, 2021, 12(4): 23-29. DOI:10.12015/issn.1674-8034.2021.04.005.

1
Baujat B, Audry H, Bourhis J, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients[J]. Int J Radiat Oncol Biol Phys, 2006, 64(1): 47-56. DOI: 10.1016/j.ijrobp.2005.06.037.
2
Zheng DC, Chen YB, Liu XY, et al. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI[J]. J Magn Reson Imaging, 2015, 41(6): 1528-1540. DOI: 10.1002/jmri.24723.
3
Chaddad A, Kucharczyk MJ, Daniel P, et al. Radiomics in glioblastoma: Current status and challenges facing clinical implementation[J]. Front Oncol, 2019, 9: 374. DOI: 10.3389/fonc.2019.00374.
4
Liu ZY, Li ZL, Qu JR, et al. Radiomics of multi-parametric MRI for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study[J]. Clin Cancer Res, 2019, 25(12): 3538-3547. DOI: 10.1158/1078-0432.CCR-18-3190.
5
Chen J, Chen Y, Zheng D, et al. Pretreatment MR-based radiomics signature as potential imaging biomarker for assessing the expression of topoisomerase II alpha (TOPO-IIα) in rectal cancer[J]. J Magn Reson Imaging, 2020, 51(6): 1881-1889. DOI: 10.1002/jmri.26972.
6
Jang HJ, Kim BC, Kim HS, et al. Comparison of RECIST 1.0 and RECIST 1.1 on computed tomography in patients with metastatic colorectal cancer[J]. Oncology, 2014, 86(2): 117-121. DOI: 10.1159/000357714.
7
Unler A, Murat A, Chinnam RB. mr2PSO: A maximum relevance minimum redundancy feature selection method based on swarm intelligence for support vector machine classification[J]. Inf Sci, 2011, 181(20): 4625-4641. DOI: 10.1016/j.ins.2010.05.037.
8
Xu L, Yang P, Liang W, et al. A radiomics approach based on support vector machine using MR images for preoperative lymph node status evaluation in intrahepatic cholangiocarcinoma[J]. Theranostics, 2019, 9(18): 5374-5385. DOI: 10.7150/thno.34149.
9
Wang G, He L, Yuan C, et al. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma[J]. Eur J Radiol, 2018, 98: 100-106. DOI: 10.1016/j.ejrad.2017.11.007.
10
Peng H, Chen L, Zhang Y, et al. The tumour response to induction chemotherapy has prognostic value for long-term survival outcomes after intensity-modulated radiation therapy in nasopharyngeal carcinoma[J]. Sci Rep, 2016, 6: 24835. DOI: 10.1038/srep24835.
11
Liu LT, Tang LQ, Chen QY, et al. The prognostic value of plasma epstein-barr viral DNA and tumor response to neoadjuvant chemotherapy in advanced-stage nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys, 2015, 93(4): 862-869. DOI: 10.1016/j.ijrobp.2015.08.003.
12
Liu SL, Sun XS, Yan JJ, et al. Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response[J]. Radiother Oncol, 2019, 137: 83-94. DOI: 10.1016/j.radonc.2019.04.020.
13
Chen B, Peng H, Sun R, et al. Optimal treatment modality for locoregionally advanced nasopharyngeal carcinoma: A literature-based network meta-analysis[J]. J Cancer, 2018, 9(1): 205-212. DOI: 10.7150/jca.22170.
14
Zheng D, Lai G, Chen Y, et al. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma[J]. J Magn Reson Imaging, 2018, 48(5): 1208-1216. DOI: 10.1002/jmri.26164.
15
Qamar S, King AD, Ai QY, et al. Amide proton transfer MRI detects early changes in nasopharyngeal carcinoma: providing a potential imaging marker for treatment response[J]. Eur Arch Otorhinolaryngol, 2019, 276(2): 505-512. DOI: 10.1007/s00405-018-5231-x.
16
Zhang B, Tian J, Dong D, et al. Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma[J]. Clin Cancer Res, 2017, 23(15): 4259-4269. DOI: 10.1158/1078-0432.CCR-16-2910.
17
Zhuo EH, Zhang WJ, Li HJ, et al. Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups[J]. Eur Radiol, 2019, 29(10): 5590-5599. DOI: 10.1007/s00330-019-06075-1.
18
Wong AJ, Kanwar A, Mohamed AS, et al. Radiomics in head and neck cancer: from exploration to application[J]. Transl Cancer Res, 2016, 5(4): 371-382. DOI: 10.21037/tcr.2016.07.18.
19
Lv W, Yuan Q, Wang Q, et al. Radiomics analysis of PET and CT components of PET/CT imaging integrated with clinical parameters: Application to prognosis for nasopharyngeal carcinoma[J]. Mol Imaging Biol, 2019, 21(5): 954-964. DOI: 10.1007/s11307-018-01304-3.
20
Shu Z, Fang S, Ding Z, et al. MRI-based radiomics nomogram to detect primary rectal cancer with synchronous liver metastases[J]. Sci Rep, 2019, 9(1): 3374. DOI: 10.1038/s41598-019-39651-y.
21
Zhao L, Gong J, Xi Y, et al. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma[J]. Eur Radiol, 2020, 30(1): 537-546. DOI: 10.1007/s00330-019-06211-x.
22
Valdora F, Houssami N, Rossi F, et al. Rapid review: radiomics and breast cancer[J]. Breast Cancer Res Treat, 2018, 169(2): 217-229. DOI: 10.1007/s10549-018-4675-4.

PREV The value of preoperative multi-parametric MR features using surface coil exclusive designed for thyroid gland in predicting the metastatic status of regional lymph nodes in thyroid cancer
NEXT Clinical value of MRI in the diagnosis of multilocular cystic renal cell carcinoma and cystic nephroma
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn